# Peter McLaughlin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/peter-mclaughlin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,230 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 84 |
| i10-index | 314 |
| Last Known Institution | Heidelberg University |
| OpenAlex ID | https://openalex.org/A5034301588 |
| ORCID iD | https://orcid.org/0000-0002-8011-642X |
| Works | 597 |

## Researcher papers

- [Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.](https://scholariq.org/papers/rituximab-chimeric-anti-cd20-monoclonal-antibody-therapy-for-relapsed-indolent/)
- [Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project](https://scholariq.org/papers/follicular-lymphoma-international-prognostic-index-2-a-new-prognostic-index-for/)
- [Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial](https://scholariq.org/papers/lenalidomide-in-combination-with-rituximab-for-patients-with-relapsed-or/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [CNS Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/cns-lymphoma-diagnosis-and-treatment/)
- [Viral-associated cancers and disorders](https://scholariq.org/topics/viral-associated-cancers-and-disorders-2/)
- [Cutaneous lymphoproliferative disorders research](https://scholariq.org/topics/cutaneous-lymphoproliferative-disorders-research/)

## Researcher university

- [Heidelberg University](https://scholariq.org/institutions/heidelberg-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.